FDA 483 - AGCO Hay LLC - April 04, 2024

An FDA inspection of AGCO HAY LLC, a beef cattle ranch in Tres Pinos, CA, revealed two significant observations. The firm was cited for extralabel drug use resulting in oxytetracycline residue above established tolerance levels in a beef cow intended for human consumption. Additionally, the inspection found that the firm failed to maintain complete medication treatment records for its animals.